Date: Friday, May 3, 2019
San Diego Convention Center
111 W Harbor Dr
San Diego, CA 92101
Continuing Medical Education
Practicing ophthalmologists who care for patients with corneal-related conditions.
At the end of the activity, participants will be able to:
- Evaluate how to integrate crosslinking into practice
- Compare and contrast modalities for ocular surface reconstruction
- Implement strategies to identify and efficiently manage patients with ocular surface disease/dry eye disease preoperatively
- Compare and contrast new advances in dry eye disease
- Incorporate methods and pearls to successfully perform anterior segment surgery with concurrent corneal disease
- Implement strategies to transition from DSAEK to DMEK
- Analyze the indications and surgical techniques for newer forms of lamellar keratoplasty
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity
The American Society of Cataract and Refractive Surgery designates this live activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 CreditTM are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 CreditTM.
Claim CME/CE Credits
Computers with internet access will be available onsite so attendees can evaluate the 2019 Cornea Day Program online through the Claim CME/CE Credit Stations. When the evaluation is complete, a copy of the certificate for continuing education credits/hours for that day can be printed. If attendees do not complete the evaluation during the meeting, they will have the opportunity to complete them at home.
Notice of Off-Label Use Presentations
The ASCRS Annual Meeting may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.